**3. Conclusions**

BCP is a plant compound which has been demonstrated to possess a grea<sup>t</sup> potential application for various pathological conditions, due, above all, to the selectivity towards CB2 receptors, which, in addition to making this sesquiterpene devoid of psychogenic e ffects typical of cannabinoids, determines its main biological e ffects. In fact, BCP contrast in the animals the inflammatory process, typical of various degenerative diseases, which involve central nervous system (Parkinson's disease, Alzheimer's disease, multiple sclerosis, amyotrophic lateral sclerosis, etc.), steatohepatitis, osteoporosis, but also cancer and *Streptococcus mutans* infections.

However, even if the studies on the molecule are very promising, these are only preclinical (in vitro or in vivo in animal models) and further insights and clinical trials are required for a future human application.

**Author Contributions:** Conceptualization, A.F.; methodology, D.I.; software, J.C.; validation, A.B. and C.S.; resources, R.M.; data curation, C.L.T.; writing—original draft preparation, F.F.; writing—review and editing, A.C.; supervision, M.S.S.

**Funding:** This research received no external funding.

**Conflicts of Interest:** The authors declare no conflict of interest.
